Safety of discontinuing antiplatelet therapy 12-24 months after stent-assisted coil embolization: a multicenter retrospective study

被引:4
|
作者
Kim, Chang Hyeun [1 ]
Hong, Noah [2 ]
Rhim, Jong-Kook [3 ]
Mun, Jong Hyeon [4 ]
Lim, Jeongwook [5 ]
Choi, Hyun Ho [6 ]
Kim, Young Ha [1 ]
Lee, Sang Weon [1 ]
Cho, Young Dae [7 ,8 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Neurosurg, Yangsan, South Korea
[2] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Neurosurg,Seoul Metropolitan Govt, Seoul, South Korea
[3] Jeju Natl Univ, Jeju Natl Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea
[4] Kwangju Christian Hosp, Dept Neurosurg, Gwangju, South Korea
[5] Chungnam Natl Univ, Sejong Hosp, Sch Med, Dept Neurosurg, Daejeon, South Korea
[6] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea
[7] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea
[8] Seoul Natl Univ, Coll Med, Seoul, South Korea
关键词
aneurysm; coil; embolization; stent; antiplatelet; vascular disorders; INTRACRANIAL ANEURYSMS;
D O I
10.3171/2023.3.JNS222177
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Antiplatelet medication is required after stent-assisted coil embolization (SACE) to avoid thromboembolic complications. Currently, there is no consensus on how long the antiplatelet agent should be maintained. The authors investigated clinical outcomes in patients who discontinued their antiplatelet agent 12-24 months after SACE. METHODS Data were retrieved from a prospective database for 373 consecutive patients with SACE at 6 institutions who discontinued antiplatelet therapy 12-24 months after SACE. Thromboembolic complications associated with discontinuation were defined as neurological or radiographic ischemia that occurred within 6 months after discontinuation of the antiplatelet agent; the lesion had to be correlated with the territory of the stented artery. RESULTS The mean time until discontinuation of the antiplatelet medication was 15.8 +/- 4.7 months after SACE (12-18 months, n = 271; 19-24 months, n = 102). The most common location of treated aneurysms was the internal carotid artery (n = 223, 59.8%). A laser-cut open-cell stent was most commonly applied (n = 236/388, 60.8%), followed by lasercut closed-cell stents (n = 119, 30.7%) and braided closed-cell (n = 33, 8.5%); double stenting was applied in 15 aneurysms. There were no patients who experienced cerebral ischemia related to discontinuation of antiplatelet medications, except for 1 patient at high risk of ischemia (0.27%, 95% CI 0.01%-1.48%). CONCLUSIONS These results suggest that it may be safe to discontinue antiplatelet medication after SACE in patients at low risk for ischemia, and that it appears safe to discontinue the agent at approximately 15 months after the procedure. Large cohort-based prospective studies or randomized clinical trials are warranted to confirm these results.
引用
收藏
页码:1311 / 1316
页数:6
相关论文
共 50 条
  • [21] Comparison of Stent-Assisted Coil Embolization and the Pipeline Embolization Device for Endovascular Treatment of Ophthalmic Segment Aneurysms: A Multicenter Cohort Study
    Adeeb, Nimer
    Griessenauer, Christoph J.
    Foreman, Paul M.
    Moore, Justin M.
    Motiei-Langroudi, Rouzbeh
    Chua, Michelle H.
    Gupta, Raghav
    Patel, Apar S.
    Harrigan, Mark R.
    Alturki, Abdulrahman Y.
    Ogilvy, Christopher S.
    Thomas, Ajith J.
    WORLD NEUROSURGERY, 2017, 105 : 206 - 212
  • [22] Stent-assisted aneurysm coil embolization: safety and efficacy at a low-volume center
    Gordhan, A.
    Invergo, D.
    NEUROLOGICAL RESEARCH, 2011, 33 (09) : 942 - 946
  • [23] Stent-assisted coil embolization of aneurysms with small parent vessels: safety and efficacy analysis
    Kuhn, Anna Luisa
    Hou, Samuel Y.
    Puri, Ajit S.
    Silva, Christine F.
    Gounis, Matthew J.
    Wakhloo, Ajay K.
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2016, 8 (06) : 581 - 585
  • [24] Comparison of stent-assisted and no-stent coil embolization for safety and effectiveness in the treatment of ruptured intracranial aneurysms
    Roh, Haewon
    Kim, Junwon
    Bae, Heejin
    Chong, Kyuha
    Kim, Jong Hyun
    Suh, Sang-il
    Kwon, Taek-Hyun
    Yoon, Wonki
    JOURNAL OF NEUROSURGERY, 2020, 133 (03) : 814 - 820
  • [25] Clinical Study on Complications of Intracranial Ruptured Aneurysm Embolization by Stent-Assisted Coil
    Liu, Yinlong
    Wang, Jianren
    Lin, Liqing
    Sang, Chunsheng
    Lin, Zexi
    Pan, Yaohua
    Fu, Xi'an
    MEDICAL SCIENCE MONITOR, 2018, 24 : 8115 - 8124
  • [26] Sub-Internal Limiting Membrane Hemorrhage after Stent-Assisted Coil Embolization
    Fukuyama, Hisashi
    Gomi, Fumi
    OPHTHALMOLOGY RETINA, 2020, 4 (09): : 926 - 926
  • [27] Angiographic findings of in-stent intimal hyperplasia after stent-assisted coil embolization: are they permanent findings?
    Kim, Young Soo
    Lee, Sang Won
    Yeom, Jeong A.
    Yoon, Chang Hyo
    Baik, Seung Kug
    JOURNAL OF NEUROSURGERY, 2016, 124 (02) : 328 - 333
  • [28] Herniated Proximal Marker of the Stent into the Meningohypophyseal Trunk after Stent-Assisted Coil Embolization for Intracranial Aneurysms
    Seung, Won-Bae
    CASE REPORTS IN NEUROLOGY, 2018, 10 (02): : 213 - 216
  • [29] Stent-assisted coiling using the Neuroform Atlas stent for treatment of aneurysms that recur after coil embolization
    Dong, Linggen
    Wang, Jiejun
    Chen, Xiheng
    Zhang, Longhui
    Zhao, Zhiqiang
    Peng, Qichen
    Jin, Zeping
    Wu, Jun
    Lv, Ming
    Liu, Peng
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [30] Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel
    Choi, Hyun Ho
    Lee, Jung Jun
    Cho, Young Dae
    Han, Moon Hee
    Cho, Won-Sang
    Kim, Jeong Eun
    An, Sang Joon
    Mun, Jong Hyeon
    Yoo, Dong Hyun
    Kang, Hyun-Seung
    NEUROSURGERY, 2018, 83 (05) : 981 - 988